LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

Go back to LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

LOGIC Devices Inc. (LOGC) Tops Q3 EPS by 3c

November 14, 2022 8:14 AM EST

LOGIC Devices Inc. (NASDAQ: LOGC) reported Q3 EPS of ($0.18), $0.03 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $2.72 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on LOGIC Devices Inc. (LOGC) click here.

... More